Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 12, 1997, Pages 4229-4233

  Holzapfel, Hans Peter ^a   Führer, Dagmar ^a   Wonerow, Peter ^a   Weinland, Gerhard ^b   Scherbaum, Werner A ^a   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b ISRAELITISCHES KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THYROTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SOMATIC MUTATION; THYROID ADENOMA; THYROID NODULE; TOXIC GOITER;

ANIMALIA;

EID: 0030735543     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.12.4229     Document Type: Article

References (33)

1. Hamburger J. 1983 The autonomously functioning thyroid adenoma. N Engl J Med. 309:1512-1513.
2. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. 1991 High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med. 229:415-420.
3. Peter HJ, Gerber H, Studer H, Smeds S. 1985 Pathogenesis of heterogenity in human multinodular goitre. A study on growth and function of thyroid tissue transplanted onto nude mice. J Clin Invest. 76:1992.
4. O'Sullivan C, Barton CM, Staddon SL, et al. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:345-349.
5. Suarez HG, du Villar JA, Caillou B, et al. 1991 gsp mutations in human thyroid tumours. Oncogene. 6:677-679.
6. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:649-651.
7. Kjelsberg MA, Cotecchia S, Ostrowski J, et al. 1992 Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site. J Biol Chem. 267:1430-1433.
8. Paschke R, Van Sande J, Parma J, Vassart G. 1996 The TSH receptor and thyroid disease. Bailliere Clin Endocrinol Metab. 10:9-28.
9. Führer D, Wonerow P, Willgerodt H, Scherbaum W, Paschke R. 1997 Identification of a new TSH receptor germline mutation in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab. 82: 4234-4238.
10. Köhler B, Biebermann H, Krohn HP, et al. A novel germline mutation in the thyrotropin receptor gene causing nonautoimmune congenital hyperthyroidism [Abstract]. Proc of the Int Congr of Endocrinol. 1996; 641.
11. Van Sande J, Parma J, Tonacchera et al. 1995 Somatic and germline mutations of the TSH receptor gene in thyroid disease. J Clin Endocrinol Metab 80:2577-2585.
12. Tonacchera M, Van Sande J, Cetani F, et al. 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab. 81:547-554.
13. 12a. Libert F, Lefort A, Gerard C, et al. 1989 Cloning, sequencing, and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochim Biophys Res Commun. 165:1250-1255.
14. Ausubel FM, Brent R, Kingston RE, et al. 1989 Current protocols in molecular biology. New York: Wiley Interscience.
15. 13a. Swillens S. 1995 Interpretation of binding curves with high receptor concentrations: practical aid for computer analysis. Mol Pharmacol. 47:1197-1203.
16. Munson PJ, Rodbard D. 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 107:220-239.
17. ++ cascades. Mol Endocrinol. 9:725-733.
18. Kopp P, Van Sande J, Parma J, et al. 1995 Brief report: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 332:150-154.
19. Paschke R, Tonacchera M, Van Sande J, et al. 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the TSH receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab. 79:1785-1789.
20. 17a. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE. 1994 Novel mutations of the thyrotropin receptor gene in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab. 79:657-661.
21. Thomas GA, Williams D, Williams ED. 1989 The clonal origin of thyroid nodules and adenomas. Am J Pathol. 134:141-147.
22. Hedinger, C, Williams, ED, Sobin, LH. 1988 Histological typing of thyroid tumours. 2nd ed. Berlin: Springer; 5-37.
23. Bahre M, Hilgers R, Lindemann C, Emrich D. 1988 Thyroid autonomy: sensitive detection in vivo and estimation of its functional relevance using quantified high-resolution scintigraphy. Acta Endocrinol (Copenh). 117:145-153.
24. Parma J, Duprez L, Van Sande J, et al. 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and a Gsx gene as a cause of toxic-thyroid adenomas. J Clin Endocrinol Metab. 82:2695-2701.
25. 21a. Führer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R. 1997 Somatic mutations in the thyrotropin receptor gene and not in the Gsα protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab. 82:3885-3891.
26. Studer H, Ramelli F. 1982 Simple goiter and its variants: euthyroid and hyperthyroid multinodular goiters. Endocr Rev. 3:40-61.
27. Dumont JE, Maenhaut C, Lamy F. 1992 Control of thyroid cell proliferation and goitrogenesis. Trends Endocrinol Metab. 3:12-17.
28. Wynford-Thomas D, Stringer BMJ, Harach H, Williams ED. 1982 Investigation of putative control mechanisms for thyroid growth. Virchows Arch. 40:379-385.
29. Ames BN, Gold LS. 1990 Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 249:970-971.
30. Dumont JE, Ermans AM, Maenhaut C, et al. 1995 Large goitre as a maladaption to iodine deficiency. Clin Endocrinol (Oxf). 43:1-10.
31. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology. 128:779-785.
32. Matsuo K, Tang SH, Zeki K, et al. 1993 Aberrant deoxyribonucleic acid methylation in human thyroid tumors. J Clin Endocrinol Metab. 77:991-995.
33. Rideout WM, Coetzee GA, Olumi AF, Jones PA. 1990 S-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 249:1288-1290.